Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancerDipesh Uprety, Ann G. Schwartz, Randell Seaton et al.|JNCI Journal of the National Cancer Institute|2024Cited by 14
Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitorsTarik Hadid, Ammar Sukari, Mohammed Najeeb Al Hallak et al.|Therapeutic Advances in Vaccines and Immunotherapy|2024Cited by 3
Evaluating artificial intelligence (AI) as a clinical decision support tool for lung cancer treatment recommendations.Roupen Odabashian, Hirva Mamdani, Jeffrey A. Karson et al.|Journal of Clinical Oncology|2025Cited by 1
EP11.01-10 Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Does Histology Matter?Khalil Choucair, Hirva Mamdani, Hagoon Jang et al.|Journal of Thoracic Oncology|2023Cited by 0
Large Language Models as a Medical Oncology Decision Support Tool: A Retrospective Study Using Real-Life Lung Cancer Cases (Preprint)Roupen Odabashian, Hirva Mamdani, Jeffrey A. Karson et al.|Unknown|2025Cited by 0